Literature DB >> 1978413

Correction of a defect in mammalian GPI anchor biosynthesis by a transfected yeast gene.

R DeGasperi1, L J Thomas, E Sugiyama, H M Chang, P J Beck, P Orlean, C Albright, G Waneck, J F Sambrook, C D Warren.   

Abstract

Glycosylphosphatidylinositol (GPI) serves as a membrane anchor for a large number of eukaryotic proteins. A genetic approach was used to investigate the biosynthesis of GPI anchor precursors in mammalian cells. T cell hybridoma mutants that cannot synthesize dolichol-phosphate-mannose (Dol-P-Man) also do not express on their surface GPI-anchored proteins such as Thy-1 and Ly-6A. These mutants cannot form mannose-containing GPI precursors. Transfection with the yeast Dol-P-Man synthase gene rescues the synthesis of both Dol-P-Man and mannose-containing GPI precursors, as well as the surface expression of Thy-1 and Ly-6A, suggesting that Dol-P-Man is the donor of at least one mannose residue in the GPI core.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978413     DOI: 10.1126/science.1978413

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  20 in total

1.  Human and Saccharomyces cerevisiae dolichol phosphate mannose synthases represent two classes of the enzyme, but both function in Schizosaccharomyces pombe.

Authors:  P A Colussi; C H Taron; J C Mack; P Orlean
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins.

Authors:  K Kodukula; R Amthauer; D Cines; E T Yeh; L Brink; L J Thomas; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 3.  Dolichol phosphate mannose synthase: a Glycosyltransferase with Unity in molecular diversities.

Authors:  Dipak K Banerjee; Zhenbo Zhang; Krishna Baksi; Jesús E Serrano-Negrón
Journal:  Glycoconj J       Date:  2017-06-14       Impact factor: 2.916

4.  Cloning and functional expression of glycosyltransferases from parasitic protozoans by heterologous complementation in yeast: the dolichol phosphate mannose synthase from Trypanosoma brucei brucei.

Authors:  R Mazhari-Tabrizi; V Eckert; M Blank; R Müller; D Mumberg; M Funk; R T Schwarz
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Saccharomyces cerevisiae GPI10, the functional homologue of human PIG-B, is required for glycosylphosphatidylinositol-anchor synthesis.

Authors:  C Sütterlin; M V Escribano; P Gerold; Y Maeda; M J Mazon; T Kinoshita; R T Schwarz; H Riezman
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

6.  The complex structures of arabinogalactan-proteins and the journey towards understanding function.

Authors:  Y Gaspar; K L Johnson; J A McKenna; A Bacic; C J Schultz
Journal:  Plant Mol Biol       Date:  2001-09       Impact factor: 4.076

7.  Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism.

Authors:  V C Taylor; M Sims; S Brett; M C Field
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

8.  Atypical mannolipids characterize Thy-1-negative lymphoma mutants.

Authors:  P Lemansky; D K Gupta; S Meyale; G Tucker; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

9.  DPM2 regulates biosynthesis of dolichol phosphate-mannose in mammalian cells: correct subcellular localization and stabilization of DPM1, and binding of dolichol phosphate.

Authors:  Y Maeda; S Tomita; R Watanabe; K Ohishi; T Kinoshita
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Differential expression of glycosylphosphatidylinositol-anchored proteins in a murine T cell hybridoma mutant producing limiting amounts of the glycolipid core. Implications for paroxysmal nocturnal hemoglobinuria.

Authors:  L J Thomas; M Urakaze; R DeGasperi; T Kamitani; E Sugiyama; H M Chang; C D Warren; E T Yeh
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.